RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS

Clinical trials for RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS trials appear

Sign up with your email to follow new studies for RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Faster fight against Super-TB for diabetics

Disease control Not yet recruiting

This study aims to see if a newer, shorter 6-month oral treatment works as well and is as safe for people with both drug-resistant tuberculosis (TB) and type 2 diabetes, compared to people with TB alone. It will enroll 60 participants aged 12 and older. Researchers will compare t…

Matched conditions: RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS

Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS

Get alerted when new RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS trials appear

Faster fight against Super-TB for diabetics